Avidity Biosciences
RNAM
#1866
Rank
โ‚ฌ9.86 B
Marketcap
63,84ย โ‚ฌ
Share price
0.00%
Change (1 day)
163.63%
Change (1 year)

EPS for Avidity Biosciences (RNAM)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,66ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,53ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ46.4%
2024-2,53ย โ‚ฌ
2022-2,92ย โ‚ฌ-9.02%
2021-3,21ย โ‚ฌ68.93%
2020-1,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,15ย โ‚ฌ-131.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,41ย โ‚ฌ-192.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-7,29ย โ‚ฌ 99.04%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
7,71ย โ‚ฌ-310.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-1,16ย โ‚ฌ-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-44,11ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,54ย โ‚ฌ-142.11%๐Ÿ‡บ๐Ÿ‡ธ USA